NEW YORK (GenomeWeb News) — The Industrial Technology Research Institute and Vita Genomics will market their pharmacogenomics services to drug developers, Vita said today.
 
Under the agreement, the companies plan to offer Vita’s high-throughput sequencing, genotyping, and gene-expression profiling, and ITRI’s proteomics databases to pharmaceutical companies.
 
Both shops are based in Taiwan. Vita has a marketing operation in the US.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

New Mexico is re-doing its proposed science education standards after criticism, the Associated Press reports.

Agbio executives say gene editing will speed up breeding efforts, according to the Wall Street Journal.

La Trobe University's Jenny Graves has won the $250,000 Prime Minister's Prize for Science, the Guardian reports.

In Cell this week: post-treatment changes to melanoma genome, multi-omics analysis of muscle-invasive bladder cancer, and more.